M14-671 Rinvoq Ph 3 CD Pediatric Study
ClinicalTrials.gov NCT06332534
Research payments
$1,014
Through program year 2024, $1,014 in research payments was reported against M14-671 Rinvoq Ph 3 CD Pediatric Study, across 8 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT06332534
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $1,014 | 8 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ramalingam Arumugam Saint Paul, MN Named on 1 payment
- Xiaoyi Zhang Indianapolis, IN Named on 1 payment
- Edwin Torres Reyes Arecibo, PR Named on 1 payment
- Thomas Sferra Cleveland, OH Named on 1 payment
- Ian Kang Baton Rouge, LA Named on 1 payment
- Mohammad Mahmud Corona, CA Named on 1 payment
- David Dunkin New York, NY Named on 1 payment
- Leonardo Hormaza Santurce, PR Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.